Last reviewed · How we verify
NCT06301048
Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma
trial testing Stent Placement in Pancreatic and Bile Ducts in Duodenal Adenoma in 79 participants. Completed in 7 December 2023.
7 December 2023
Quick facts
| Lead sponsor | Beijing Friendship Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 79 |
| Start date | 7 November 2023 |
| Primary completion | 7 December 2023 |
| Estimated completion | 7 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Stent Placement in Pancreatic and Bile Ducts
Conditions studied
- Duodenal Adenoma — all drugs for Duodenal Adenoma →
- Complication of Treatment — all drugs for Complication of Treatment →
Sponsor
Beijing Friendship Hospital
Who can join
18 and older, any sex, with Duodenal Adenoma or Complication of Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a retrospective study, including 79 patients with duodenal papillary adenoma, who treated with Endoscopic Papillectomy (EP) at Beijing friendship hospital. The cohort included patients who underwent EP with or without Pancreatic Duct (PD) and Common Bile Duct (CBD) stent placement. The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of endoscopic papillectomy with stent placement in pancreatic and bile ducts for treating duodenal papillary adenoma: a retrospective study.
Jiang J, Lv F, Chen C, Jiang W. · · 2024 · PMID 39448906 · DOI 10.1186/s12876-024-03466-7
Verify or expand the search:
- PubMed search for NCT06301048
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Duodenal Adenoma
Currently open trials in the same condition.
- NCT07461246 — Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare) · active not recruiting
- NCT06435533 — Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis · NA · recruiting
- NCT07199127 — Duodenal Polyposis Classification in FAP · recruiting
Other Beijing Friendship Hospital trials
Trials by the same sponsor.
- NCT07453862 — Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety · Phase 1 · recruiting
- NCT07397442 — Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer · Phase 2 · not yet recruiting
- NCT07393048 — Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant The · recruiting
- NCT07441850 — Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy · NA · recruiting
- NCT07369739 — Golidocitinib Combined With Selinexor for CAEBVD · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06301048 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Friendship Hospital
- Last refreshed: 8 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06301048.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing